As of 2026-09-11, the Relative Valuation of Arbutus Biopharma Corp (ABUS) is 16.74 USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.12 USD, the upside of Arbutus Biopharma Corp based on Relative Valuation is 227.0%.
The range of the Relative Valuation is 12.85 - 19.28 USD.
| Range | Selected | |
| Trailing P/E multiples | 19.2x - 23.6x | 21.4x |
| Forward P/E multiples | 15.8x - 23.7x | 19.8x |
| Fair Price | 12.85 - 19.28 | 16.74 |
| Upside | 151.1% - 276.6% | 227.0% |
| Date | P/E |
| 2026-09-08 | 6.37 |
| 2026-09-04 | 6.33 |
| 2026-09-03 | 6.29 |
| 2026-09-02 | 6.27 |
| 2026-09-01 | 6.26 |
| 2026-08-31 | 6.24 |
| 2026-08-28 | 6.23 |
| 2026-08-27 | 6.35 |
| 2026-08-26 | 6.38 |
| 2026-08-25 | 6.39 |
| 2026-08-24 | 6.39 |
| 2026-08-21 | 6.40 |
| 2026-08-20 | 5.86 |
| 2026-08-19 | 6.12 |
| 2026-08-18 | 5.95 |
| 2026-08-17 | 5.79 |
| 2026-08-14 | 5.74 |
| 2026-08-13 | 5.63 |
| 2026-08-12 | 5.64 |
| 2026-08-11 | 5.74 |
| 2026-08-10 | 5.64 |
| 2026-08-07 | 5.69 |
| 2026-08-06 | 5.58 |
| 2026-08-05 | 5.68 |
| 2026-08-04 | 5.43 |
| 2026-08-03 | 5.36 |
| 2026-07-31 | 5.33 |
| 2026-07-30 | 5.42 |
| 2026-07-29 | 5.27 |
| 2026-07-28 | 5.42 |
| 2026-07-27 | 5.42 |
| 2026-07-24 | 5.38 |
| 2026-07-23 | 5.49 |
| 2026-07-22 | 5.32 |
| 2026-07-21 | 5.56 |
| 2026-07-20 | 5.42 |
| 2026-07-17 | 5.60 |
| 2026-07-16 | 5.83 |
| 2026-07-15 | 5.60 |
| 2026-07-14 | 5.67 |
| 2026-07-13 | 5.73 |
| 2026-07-10 | 5.90 |
| 2026-07-09 | 6.32 |
| 2026-07-08 | 6.42 |
| 2026-07-07 | 6.37 |
| 2026-07-06 | 6.11 |
| 2026-07-02 | 5.99 |
| 2026-07-01 | 5.81 |
| 2026-06-30 | 5.90 |
| 2026-06-29 | 5.75 |